NCT05085860Completed
Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation
Feasibility of Examining Acute Responses to Exercise in Symptomatic Females and Males With Atrial Fibrillation: a Pilot Randomized Crossover Study
Source: ClinicalTrials.gov · Last updated 25 Jun 2026
Brief summary (registry, in English)
The main purpose of this pilot project is to measure the feasibility of conducting a randomized crossover study examining short-term changes in atrial fibrillation (AF) symptoms in symptomatic females and males with paroxysmal or persistent AF when they engage in a standard week of exercise (i.e. moderate-intensity continuous training \[MICT\] or high-intensity interval training \[HIIT\]) compared to a control week (i.e. no moderate to vigorous exercise over 7 days).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 25 (actual)
- First submitted
- 13 Sept 2021
- Start date
- 8 Feb 2022
- Primary completion date
- 21 Jul 2024
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Diseases
- Atrial fibrillation
- NCT number
- NCT05085860
What you commit to
- Study type: Interventional
- Participants enrolled: 25
- From 8 Feb 2022 to the primary completion date, 21 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Unstable angina or uncontrolled diabetes mellitus; or established diagnosis of severe mitral or aortic stenosis, or hypertrophic obstructive cardiomyopathy with significant obstruction
- Unwilling or unable to complete the three conditions
Other
- Currently participating in routine exercise training
- Unable to access the Internet or a phone (iPhone and iPad require iOS version 10.0 and up, Android requires version 6.0 and up) during the study period
- Has an automated external defibrillator, an implantable cardioverter defibrillator or other types of pacemaker
- Unable to provide written, informed consent
Who the study is looking for
- Paroxysmal and Persistent AF
- Rate controlled (resting ventricular rate \<110 bpm)
- Able to do a symptom limited exercise test
- At least 40 years of age
- Self-reports being symptomatic in the past 4 weeks
- If female, self-reports being post-menopausal
- Able to read and understand English or French
- Agrees to sign informed consent
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Ottawa Heart Institute Coordinator of this site? Confirm its status | Ottawa | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.